Bayer AG announced on Tuesday that its sales in the first quarter of the fiscal year 2026 stood at €13.4 billion, down 2.4% compared to the same period a year prior. The figure matched analysts' expectations. Net income soared 112.7% to €2.7 billion while its earnings per share jumped from €1.32 reported the year before to €2.81.
The pharmaceutical company's full-year outlook includes free cash flow expected to amount to between €2 billion and €3 billion in 2026. Sales are forecast in a range between €45 billion and €47 billion compared to the previous range of €44 billion and €46 billion.
"The war in the Middle East is weighing on the global economic environment, reinforcing our expectations that the world economy will grow by a below-average, low single-digit percentage in 2026 (based on International Monetary Fund data)," the statement showed.
https://breakingthenews.net/Article/Bayer's-Q1-sales-down-2.4-to-euro13.4-billion/66269865
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.